Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2020

Apr 4, 2020

33899_dirs_2020-04-03_4518921c-3156-4e6d-aaf7-43baade7f9f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2020-04-01

Reporting Person: KELLEMAN JOSEPH P ((Interim) CFO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2740 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options $66.68 2028-02-07 Common Stock (1250) Direct
Stock Options $44.73 2027-02-16 Common Stock (1250) Direct

Footnotes

F1: Includes 237 shares of common stock underlying a restricted stock award which was granted on February 22, 2019 and will vest in equal installments on February 22, 2021 and 2022 and 449 shares of common stock underlying a restricted stock award granted on February 21, 2020 which will vest in equal installments on the first, second and third anniversary of the date of grant.

F2: Includes 417 non-qualified stock options which were granted on February 7, 2018 and will vest on February 7, 2021.